Could a simple blood test predict lupus in children with ITP?
NCT ID NCT07680010
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study looks at children with immune thrombocytopenic purpura (ITP) who also have certain antibodies, as they are at higher risk of developing lupus. Researchers will analyze blood samples to track immune cell changes and markers that may signal the transition to lupus. The goal is to better understand how lupus begins and find ways to prevent it in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could reveal early warning signs of lupus in children with ITP, pointing toward ways to prevent lupus before it starts.
What could go wrong
This is an observational study, not a treatment trial. It may not lead to immediate prevention strategies, and findings may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
CHU Toulouse - Hôpital des Enfants
Toulouse, 31026, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chu de Bordeaux- Groupe Hospitalier Pellegrin - Hôpital des Enfants
Bordeaux, 33076, France
Contact Phone: •••-•••-•••• Email: •••••@•••••